Loading…
To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 7,255 other HR bills in the 110th — cohort avg 47d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2008 · second_quarter · Animals
1. Educated policymakers on the lack of scientific basis for, and potential impacts of, a listing under the Endangered Species Act of the polar bear; 2. Supported legislation to provide incentives to landowners to protect species (H.R. 700, H.R. 1422, H.R. 2223).
Client expense: Not reported · Firm income: $50,000
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: Agriculture, Dept of (USDA), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE
2007 · year_end · Health Issues
Immunosuppressive Drug / Transplantation Legislation S. 178 / H.R. 2223
Client expense: $45,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| KY |
| Thaddeus McCotter | Republican | MI |